ClinicalTrials.Veeva

Menu

7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy

C

Chinese PLA General Hospital (301 Hospital)

Status

Not yet enrolling

Conditions

MRI
fMRI Research
Hepatic Encephalopathy (HE)

Treatments

Other: 7.0T MRI-Scan

Study type

Observational

Funder types

Other

Identifiers

NCT06923254
Hepatic encephalopathy-301

Details and patient eligibility

About

This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).

Full description

In this study, we analyzed the imaging characteristics of HE. First, with the advantages of 7TMRI, we analyzed the differences in imaging characteristics between HE patients and the healthy, including brain functional imaging and structural imaging. Second, we analyzed the differences in imaging characteristics between different subgroups of HE patients. Finally, we analyzed the correlation between the prognostic results of HE patients after follow-up and the imaging characteristics.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with clinical suspected or diagnosed hepatic encephalopathy according to relevant guidelines.The patient's education level is above primary school level.
  • Regular follow-up.

Exclusion criteria

  • Contraindications to MRI.
  • Patients with cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease.

Trial design

200 participants in 1 patient group

7.0T Research
Description:
With the advantages of 7.0TMRI, we detect the imaging characteristics of patients with hepatic encephalopathy (HE).
Treatment:
Other: 7.0T MRI-Scan

Trial contacts and locations

1

Loading...

Central trial contact

Jing Tang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems